Last reviewed · How we verify

NCT05794126

A Clinical Comparison of Two Soft Multifocal Contact Lenses

Completed NA Results posted Last updated 10 April 2024
What this trial tests

NA trial testing Lens 1 in Presbyopia in 47 participants. Completed in 23 March 2023.

Timeline
1 February 2023
Primary endpoint
23 March 2023
23 March 2023

Quick facts

Lead sponsorCooperVision, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment47
Start date1 February 2023
Primary completion23 March 2023
Estimated completion23 March 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

CooperVision, Inc.

Who can join

42 and older, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Subjective Overall Score Primary · 15 Minutes

Subjective Overall Score was assessed using the 0-100 visual analogue scale where 0=Extremely poor, cannot use lenses and 100=Excellent=Highly impressed with these lenses overall

GroupValue95% CI
Lens 171.4± 18.0
Lens 280.3± 14.7
Subjective Comfort Secondary · 15 Minutes

Subjective Comfort Score was assessed using the 0-100 visual analogue scale where 0=Extremely uncomfortable, causes pain, cannot be tolerated and 100=Excellent, cannot be felt

GroupValue95% CI
Lens 175.0± 20.9
Lens 288.9± 12.2
Subjective Vision Secondary · 15 Minutes

Subjective Vision Score (distance and near) was assessed using the 0-100 visual analogue scale where 0=Unacceptable, cannot be worn and 100=Excellent, unaware of any visual loss

Distance Vision
GroupValue95% CI
Lens 172.3± 17.1
Lens 278.4± 15.8
Near Vision
GroupValue95% CI
Lens 177.4± 18.2
Lens 279.6± 15.7

Sponsor's own description

The study objective was to gather short-term clinical performance data for two soft multifocal contact lenses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Human retinal secretome: A cross-link between mesenchymal and retinal cells.
    Donato L, Scimone C, Alibrandi S, Scalinci SZ, et al · · 2023 · cited 6× · PMID 37545752 · DOI 10.4252/wjsc.v15.i7.665

Verify or expand the search:

Other trials of Lens 1

Trials testing the same drug.

Other recruiting trials for Presbyopia

Currently open trials in the same condition.

Other CooperVision, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05794126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing